Ornipressin acetate is a synthetic peptide active pharmaceutical ingredient (API) and a vasopressin analog with potent vasoconstrictive activity. It is used clinically to control bleeding and treat hypotension, especially in gastrointestinal bleeding and surgical settings, by reducing blood flow to splanchnic circulation. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include 8-Ornithinevasopressin, 8-L-Ornithine-vasopressin and acetate. Its PubChem CID is 66577106.
Ornipressin acetate
| CAS No | 914453-98-8 |
|---|---|
| Molecular Formula | C47H67N13O14S2 |
| Molecular Weight | 1102.2 g/mol |
| Synonyms | acetic acid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ornipressin acetate is a synthetic peptide active pharmaceutical ingredient (API) and a vasopressin analog with potent vasoconstrictive activity.
The listed CAS number is 914453-98-8.
The listed molecular formula is C47H67N13O14S2.
The listed molecular weight is 1102.2 g/mol.
acetic acid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide.
The source lists 8-Ornithinevasopressin, 8-L-Ornithine-vasopressin and acetate.